News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,229 Results
Type
Article (13584)
Company Profile (110)
Press Release (247535)
Section
Business (87948)
Career Advice (461)
Deals (15324)
Drug Delivery (64)
Drug Development (36530)
Employer Resources (49)
FDA (6259)
Job Trends (6184)
News (150028)
Policy (14007)
Tag
Academia (435)
Alliances (23093)
Alzheimer's disease (351)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4325)
Biotechnology (44)
Breast cancer (42)
Cancer (313)
Career advice (405)
Cell therapy (44)
Clinical research (30398)
Collaboration (154)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (343)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31560)
Employer resources (43)
Events (36732)
Executive appointments (171)
FDA (6438)
Funding (104)
Gene therapy (59)
GLP-1 (292)
Government (1266)
Healthcare (3521)
Infectious disease (764)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5816)
Job creations (2049)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9541)
Metabolic disorders (166)
Neuroscience (449)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (432)
Obesity (99)
Opinion (109)
Patents (52)
People (28454)
Pharmaceutical (64)
Phase I (7903)
Phase II (12855)
Phase III (11551)
Pipeline (183)
Policy (45)
Postmarket research (1399)
Preclinical (3164)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9821)
Research institute (562)
Resumes & cover letters (55)
Southern California (435)
Startups (1624)
United States (4255)
Vaccines (112)
Weight loss (78)
Date
Today (34)
Last 7 days (266)
Last 30 days (1242)
Last 365 days (12695)
2024 (11587)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19790)
Australia (2559)
California (1004)
Canada (598)
China (111)
Colorado (41)
Connecticut (41)
Europe (38776)
Florida (149)
Illinois (110)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (154)
Massachusetts (876)
Minnesota (56)
New Jersey (420)
New York (278)
North Carolina (277)
Northern California (432)
Pennsylvania (284)
South America (498)
Southern California (435)
Texas (137)
Virginia (40)
Washington State (70)
261,229 Results for "saptalis pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Appili Therapeutics Expands ATI-1501 Commercial Agreement with Partner Saptalis Pharmaceuticals
Appili Therapeutics Inc. announced today it has amended its agreement with Saptalis Pharmaceuticals LLC o expand the territories in which Saptalis will commercialize ATI-1501, Appili’s liquid oral reformulation of the antibiotic metronidazole.
February 8, 2022
·
5 min read
FDA
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
Appili Therapeutics Inc. today announced that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC (“Saptalis”) received approval from the U.S. Food and Drug Administration (“FDA”) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).
September 25, 2023
·
5 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
Press Releases
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
November 15, 2024
·
9 min read
Press Releases
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
October 28, 2024
·
9 min read
BioMidwest
Aurorium Launches Haelium™ Pharmaceutical Solutions
Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.
June 25, 2024
·
2 min read
Business
Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL)
Micro Labs USA , Inc. and Saptalis Pharmaceuticals, LLC. are strengthening their association with the launch of Metformin Oral Solution in the US market. Metformin Oral Solutio
May 13, 2020
·
3 min read
1 of 26,123
Next
